The global DNA & gene chip market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.
Conventional
means of gene analysis allow investigation of relatively small amounts of genes
at a time, which further emphasizes on the uptake of DNA microarray technology.
DNA microarray technology allows concurrent analysis of very large numbers of
nucleic acid fragments in a single experiment.
Continuous
development of new tools to support and enhance the reliability of DNA
microarray technology is likely to drive this market at a significant pace in
the foreseeable future. Furthermore, healthcare entities are engaged in
exploiting novel solutions for enhancing and combining data generated from gene
chip with data generated from high throughput technologies. Mutually beneficial
partnerships between microarray developers and pharmaceutical/biopharmaceutical
companies for the acceleration of genomic and biomedical research activities is
anticipated to spur market growth in the coming years.
Full Research Report On DNA & Gene Chip Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/dna-gene-chip-market
DNA & Gene
Chip Market Report Highlights
- Based on
product, consumables dominated the market with the largest share. This is
due to the presence of a large number of entities engaged in providing
reagents and kits associated with the use of DNA chips
- The cancer
treatment and diagnosis segment accounts for a significant share in the
market owing to the rising inclination toward development of companion
diagnostics and growing usage of DNA microarrays in cancer diagnosis and
treatment
- Implementation
of gene chip for drug discovery is also expected to increase in the coming
years owing to the growing demand for personalized medicine
- By end use,
academic/government research institutes accounted for the largest share in
2017. Ongoing research projects on gene expression analysis in these
institutes have attributed to the estimated share
- In terms of
region, North America dominated the market in terms of revenue. High
penetration of major revenue-generating companies in the U.S. has
contributed to its leading share
- Asia Pacific
is projected to witness the fastest year-on-year growth owing to rising
healthcare spending in developing economies and an increase in R&D
investment
- Some of the
prominent market participants are Agilent Technologies; Thermo Fisher
Scientific, Incorporated (Affymetrix, Inc.); Illumina, Inc.; Macrogen
Inc.; and Arrayit Corporation. These players are engaged in mutual partnerships
with research communities and other diagnostic firms for the use of gene
chips for targeting disease prognosis.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/dna-gene-chip-market/request/rs1
DNA & Gene
Chip Market Segmentation
Grand View Research has
segmented the global DNA & gene chip market on the basis of application,
product, end use, and region:
DNA & Gene
Chip Application Outlook (Revenue, USD Million, 2014 - 2025)
- Cancer diagnosis and treatment
- Gene expression
- Genotyping
- Genomics
- Drug discovery
- Agricultural biotechnology
- Others
DNA & Gene
Chip Product Outlook (Revenue, USD Million, 2014 - 2025)
- Consumables
- Instrumentation
DNA & Gene
Chip End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Academic & Government Research Institutes
- Hospitals & Diagnostics Centers
- Biotechnology & Pharmaceutical Companies
- Others
DNA & Gene
Chip Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment